Corbus Pharmaceuticals Holding

Healthcare · Biotechnology

7.10$ -4.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Corbus Pharmaceuticals Holding (CRBP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 127 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRBP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	20	18	51	45	38	67	77	70	61	47	101	84	68	49	65	98	96	102	140	121	120	108	96	82	74	66	52	44	36	28	126	152	164	156	140	125	110	168	144	127
Current Assets	19	17	50	44	38	66	74	68	58	44	93	75	58	38	55	88	85	92	130	112	112	100	88	75	67	60	46	38	31	24	122	148	161	153	137	123	108	167	144	123
Cash	19	15	49	43	37	63	71	65	56	42	90	73	55	32	47	63	82	85	67	36	37	25	57	26	12	17	7.3	8.3	11	14	14	24	19	17	19	20	27	28	26	23
Cash & Short-Term Investments	19	15	49	43	37	63	71	65	56	42	90	73	55	32	47	63	82	85	124	106	107	98	86	73	66	59	44	37	29	21	120	147	159	149	133	117	104	164	139	118
Receivables	1.3	1.3	1.3	–	0.5	–	0.9	–	–	–	–	–	–	2.7	4.4	22	1.0	2.6	2.3	2.4	2.5	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.5	1.5	1.5	–	–
Inventory	0.0	0.0	0.0	0.0	0.2	0.0	-0.9	0.0	0.0	–	–	–	–	-2.7	0.0	–	0.4	0.4	0.4	0.1	0.2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	0.3	0.4	0.4	0.4	0.3	1.4	2.6	2.7	2.7	2.7	2.7	2.9	4.9	5.1	4.9	4.5	4.4	9.3	3.8	8.5	7.4	7.0	6.6	6.2	5.9	5.5	1.4	1.3	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	6.4	9.0	7.0	7.0	6.4	9.2	12	15	18	19	59	37	38	43	43	50	67	57	49	44	42	39	35	33	32	33	35	34	36	35	29	26	14	13	13	14	17	21	18	25
Current Liabilities	6.4	8.9	7.0	6.9	6.3	8.2	10	13	17	18	52	29	31	35	35	42	41	32	24	19	17	17	15	16	17	13	14	16	32	32	26	24	12	12	12	13	17	21	18	21
Short-Term Debt	0.3	0.3	0.2	0.0	0.0	0.3	0.2	0.1	–	0.4	0.5	0.7	0.4	1.3	1.2	1.0	1.0	1.7	1.4	1.2	1.1	5.0	6.8	8.8	11	4.4	6.5	8.4	19	18	14	12	1.6	1.6	1.7	1.7	1.7	1.6	1.2	1.0
Accounts Payable	2.8	3.4	3.3	3.9	3.8	3.1	4.2	3.1	6.2	6.3	9.0	7.5	6.2	11	10.0	13	11	7.4	3.6	1.9	2.5	1.8	2.7	2.0	1.4	2.2	1.3	1.5	4.7	3.2	2.1	1.2	2.9	4.8	4.1	4.0	2.7	2.2	0.4	5.3
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	7.1	–	–	–	–	–	18	18	18	18	19	16	14	12	9.4	16	14	11	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	13	8.9	44	38	32	58	66	55	43	28	42	47	30	6.2	23	48	29	45	92	77	78	69	61	49	42	33	16	9.5	0.3	-6.9	97	126	150	142	127	111	92	148	126	102
Retained Earnings	-26	-33	-41	-48	-55	-66	-77	-89	-104	-121	-148	-145	-166	-193	-222	-261	-295	-304	-320	-337	-339	-350	-359	-372	-381	-392	-410	-419	-429	-437	-444	-454	-467	-477	-494	-512	-535	-555	-578	-613
Shares Outstanding	1.5	1.5	1.5	1.7	1.7	1.9	1.9	1.9	1.9	1.9	2.1	2.3	2.2	2.2	2.3	2.5	2.7	2.9	3.9	3.9	4.2	4.2	4.2	4.2	4.2	4.2	4.2	4.3	4.4	4.4	2.8	2.8	12	12	12	12	12	13	19	19

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings